Gut and Tumor Microbiome in Patients With Advanced ER-positive and HER2-negative Breast Cancer or Advanced Melanoma Undergoing PD-1 Checkpoint Inhibitor Therapy.

Conditions: Breast Cancer; Melanoma Interventions: Other: Observation Sponsors: BioCorteX Inc; Tempus Labs Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials